Can lowering cholesterol more aggressively help seniors with heart disease?
NCT ID NCT05361421
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two cholesterol-lowering strategies in adults aged 75 and older who have heart or blood vessel disease. One group aims for a very low LDL cholesterol target (below 55 mg/dL) using high-intensity statins, while the other receives standard moderate-intensity statin therapy. The goal is to see if the more aggressive approach reduces the risk of heart-related death, heart attacks, strokes, or the need for procedures to open blocked arteries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yonsei University Health System, Severance Hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- Virtual fitness for aging hearts: a new frontier in cardiac rehab?
- Could a simple annual blood test shield cancer survivors from heart attacks and strokes?
- Heart surgery recovery gets a wireless watchdog
- Your smartwatch may predict a heart attack days before it happens
- Fish oil may unlock heart protection for dialysis patients